巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Zynerba Pharmaceuticals

    ZYNE
    1.360
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Zynerba Pharmaceuticals - 延遲價格・最後更新於 15/08 22:00
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    1.360
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    62.22
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    4.650 - 0.836
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Zynerba Pharmaceuticals
    證券代碼
    ZYNE.US
    所屬板塊
    Drug Manufacturers - Specialty & Generic
    公司業務
    Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.
    發行量
    41217537
    公司總部
    80 West Lancaster Avenue, Suite 300
    公司網址
    http://www.zynerba.com
    公司電郵
    robertsw@zynerba.com
    公司電話
    +1 484 581-7505
    暫無內容

    關於

    Zynerba Pharmaceuticals(ZYNE.US)所屬的行業板塊為Drug Manufacturers - Specialty & Generic。
    Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.
    詳細公司背景可參考: http://www.zynerba.com